Handelsbanken Fonder AB - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$160,000
-37.5%
28,0000.0%0.00%0.0%
Q4 2021$256,000
-14.4%
28,0000.0%0.00%
-50.0%
Q3 2021$299,000
-31.3%
28,0000.0%0.00%0.0%
Q2 2021$435,000
+23.6%
28,000
+29.0%
0.00%0.0%
Q1 2021$352,000
+28.0%
21,700
+66.9%
0.00%0.0%
Q4 2020$275,000
+42.5%
13,0000.0%0.00%
+100.0%
Q3 2020$193,000
-49.5%
13,000
-50.0%
0.00%
-50.0%
Q2 2020$382,00026,0000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders